Published in Minerva Chir on June 01, 2003
Diagnosis of benign and malignant portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma: color Doppler US, contrast-enhanced US, and fine-needle biopsy. Abdom Imaging (2007) 1.20
Oxidative stress and ERK1/2 phosphorylation as predictors of outcome in hepatocellular carcinoma patients treated with sorafenib plus octreotide LAR. Cell Death Dis (2011) 1.14
BRAF and PIK3CA genes are somatically mutated in hepatocellular carcinoma among patients from South Italy. Cell Death Dis (2012) 1.05
Effects of fibronectin and laminin on structural, mechanical and transport properties of 3D collageneous network. J Mater Sci Mater Med (2007) 1.02
Ultrasound scissors versus electrocautery in axillary dissection: our experience. G Chir (2010) 1.01
Genetics and clinicopathological findings in thyroid carcinomas associated with familial adenomatous polyposis. Am J Pathol (1999) 1.01
Carnitine: an osmolyte that plays a metabolic role. J Cell Biochem (2000) 0.96
[Non recurrent inferior laryngeal nerve: our surgical experience]. Clin Ter (2009) 0.92
Biliary tract injuries during laparoscopic cholecystectomy: three case reports and literature review. G Chir (2010) 0.92
Everolimus is an active agent in medullary thyroid cancer: a clinical and in vitro study. J Cell Mol Med (2012) 0.92
Nanotech revolution for the anti-cancer drug delivery through blood-brain barrier. Curr Cancer Drug Targets (2012) 0.91
Cancer and anticancer therapy-induced modifications on metabolism mediated by carnitine system. J Cell Physiol (2000) 0.90
Seeding from hepatocellular carcinoma after percutaneous ablation: color Doppler ultrasound findings. Abdom Imaging (2005) 0.89
Childhood hepatocellular tumors in FAP. Gastroenterology (1997) 0.88
[Intrahepatic cholangiocarcinoma: case report]. Suppl Tumori (2006) 0.87
Thyroid carcinoma usually occurs in patients with familial adenomatous polyposis in the absence of biallelic inactivation of the adenomatous polyposis coli gene. J Clin Endocrinol Metab (2001) 0.85
Which therapy to prevent post-thyroidectomy hypocalcemia? G Chir (2005) 0.85
Telecardiotocography in prenatal telemedicine. J Telemed Telecare (2001) 0.84
Helicobacter pylori and gastric epithelial cells: from gastritis to cancer. J Exp Clin Cancer Res (2005) 0.83
Modulation of apelin and APJ receptor in normal and preeclampsia-complicated placentas. Histol Histopathol (2007) 0.83
Phase I dose escalation study of gemcitabine and paclitaxel plus colony-stimulating factors in previously treated patients with advanced breast and ovarian cancer. Clin Oncol (R Coll Radiol) (2000) 0.83
Galectin-3 expression in thyroid fine needle cytology (t-FNAC) uncertain cases: validation of molecular markers and technology innovation. J Cell Physiol (2013) 0.83
[Atypical mycobacterial infection after kidney transplant: two clinical cases]. G Ital Nefrol (2013) 0.82
[Retroperitoneal dedifferentiated liposarcoma (DDLS) with hyperglycemic activity: case report and literature review]. Minerva Chir (2010) 0.82
[Thyroid ectopia: problems in diagnosis and therapy]. G Chir (2010) 0.80
New trends on fibrin glue in seroma after axillary lymphadenectomy for breast cancer. G Chir (2009) 0.80
Phase I-II study of gemcitabine and paclitaxel in pretreated patients with stage IIIB-IV non-small cell lung cancer. Lung Cancer (2000) 0.80
Impact of surgical treatment on quality of life of patients with gastrointestinal tumors. Ann Oncol (2001) 0.80
An avian serum alpha 1-glycoprotein, hemopexin, differing significantly in both amino acid and carbohydrate composition from mammalian (beta-glycoprotein) counterparts. Biochemistry (1986) 0.80
Cross-linked hyaluronic acid sub-micron particles: in vitro and in vivo biodistribution study in cancer xenograft model. J Mater Sci Mater Med (2013) 0.80
Carnitine protects the molecular chaperone activity of lens alpha-crystallin and decreases the post-translational protein modifications induced by oxidative stress. FASEB J (2001) 0.79
Serum insulin-like growth factor 1 correlates with the risk of nodal metastasis in endocrine-positive breast cancer. Curr Oncol (2013) 0.79
Epidermal growth factor receptor and thyrotropin response in human thyroid tissues. J Endocrinol Invest (1990) 0.79
[Early detection of chronic kidney disease: epidemiological data on renal dysfunction]. G Ital Nefrol (2008) 0.78
Inhibition mechanisms of HIV-1, Mo-MuLV and AMV reverse transcriptases by Kelletinin A from Buccinulum corneum. Experientia (1996) 0.78
Modulation of in vitro myogenesis induced by different polymer substrates. J Mater Sci Mater Med (2004) 0.78
Major complications in thyroid surgery: utility of bipolar vessel sealing (Ligasure Precise). G Chir (2005) 0.78
Atrial natriuretic factor in amniotic fluid and in maternal venous blood of pregnancies with fetal cardiac malformations and chromosomal abnormalities. J Matern Fetal Neonatal Med (2002) 0.78
Communication of information to patients with inflammatory bowel disease: A European Collaborative Study in a multinational prospective inception cohort. J Crohns Colitis (2008) 0.78
Long-term outcomes following "presumed" total parathyroidectomy for secondary hyperparathyroidism of chronic kidney disease. G Chir (2012) 0.78
Vitronectin absorbed on nanoparticles mediate cell viability/proliferation and uptake by 3T3 Swiss albino mouse fibroblasts: in vitro study. Biomed Res Int (2013) 0.77
Effects of gonadotropin-releasing hormone agonists on uterine volume and vasculature and on the immunohistochemical expression of basic fibroblast growth factor (bFGF) in uterine leiomyomas. Int J Gynecol Pathol (2003) 0.77
Immunogold labelling in environmental scanning electron microscopy: applicative features for complementary cytological interpretation. J Microsc (2011) 0.77
Fibrin glue to reduce seroma after axillary lymphadenectomy for breast cancer. Minerva Chir (2008) 0.77
[Is extrauterine endometriosis confined to the gynecological sphere? A critical review of the experience in a general surgery unit]. G Chir (2007) 0.77
Surgical treatment of differentiated thyroid carcinoma: a retrospective study. G Chir (2008) 0.76
Cell division cycle alterations and human tumors. Adv Exp Med Biol (1999) 0.76
Ablation of large HCCs using a new saline-enhanced expandable radiofrequency device(). J Ultrasound (2009) 0.76
Ductal carcinoma in situ of the breast: our experience. G Chir (2009) 0.76
Two Case Reports of Biliary Tract Injuries during Laparoscopic Cholecystectomy. ISRN Gastroenterol (2011) 0.75
[Enzymatic changes in the lymph in the thoracic duct and right lymphatic duct during extracorporeal circulation in the dog (author's transl)]. J Chir (Paris) (1977) 0.75
[Interstitial laser treatment of small hepatocarcinoma on cirrhosis without anesthesia: feasibility study]. Suppl Tumori (2006) 0.75
[Intrahepatic biliary cystadenoma: case report]. Suppl Tumori (2006) 0.75
Surgical treatment with Ligasure Precise of schwannoma of brachial plexus: case report. G Chir (2007) 0.75
[Surgical treatment of sinus pilonidalis by Dufourmentel's flap technique]. G Chir (2007) 0.75
[Renal dysfunction as a marker of cardiovascular risk]. G Ital Nefrol (2009) 0.75
[Interstitial laser photocoagulation in liver tumours: our experience]. G Chir (2005) 0.75
[Male breast cancer. Five years experience and literature review]. G Chir (2006) 0.75
[Radio-guided surgery in follicular neoplasms of the thyroid]. Suppl Tumori (2006) 0.75
["Short" orthotopic autologous transplantation of the small intestine in dogs. Results after 10 months]. Minerva Chir (1978) 0.75
[Lymphatic drainage during extracorporeal circulation and hypothermic circulatory arrest in dogs. Analysis of the lymph and technic of catheterization of the duct by thoracic approach through the innominate vein]. Arch Chir Torac Cardiovasc (1977) 0.75
[Efficacy of somatostatin analogs in the treatment of neuroendocrine tumours and paraneoplastic syndromes]. Minerva Endocrinol (2001) 0.75
Breast surgery and sentinel node biopsy. Our experience. G Chir (2006) 0.75
[Postoperative hypothyroidism in nodular toxic goiter]. Ann Ital Chir (1990) 0.75
[Survival is not enough: improving quality of life]. G Ital Nefrol (2008) 0.75
Gangliosides and phospholipids in human thyroids responsive and unresponsive to thyrotropin. J Endocrinol Invest (1990) 0.75
[Total body washout (T.B.W.) in the rat. 1) Perfusion techniques]. Boll Soc Ital Biol Sper (1980) 0.75
[Total implantable venous systems in day surgery]. Tumori (2003) 0.75
[Biological protection of the extra-situ isolated liver. Experimental research]. Minerva Chir (1978) 0.75
[Surgical treatment of diffuse toxic goiter]. Ann Ital Chir (1990) 0.75
[Total body washout (T.B.W.) in the rat. II) Instrumental and laboratory controls]. Boll Soc Ital Biol Sper (1980) 0.75
[Post-thyroidectomy hypocalcemia. Personal experience]. Minerva Endocrinol (2002) 0.75
[Bile leakage after laparoscopic cholecystectomy: report of three cases in our experience]. G Chir (2005) 0.75
[Associated malformations of the thoracic wall and lung: etiopathogenetic and clinical considerations]. Arch Monaldi (1975) 0.75
[Differentiated thyroid carcinoma. Prognosis and therapy]. Minerva Chir (2001) 0.75
Gastrointestinal tumours in elderly. Acta Biomed (2005) 0.75
[Primary lymphoma of the gastrointestinal tract]. Minerva Chir (2001) 0.75
[Surgical treatment of hyperthyroidism in the elderly]. Ann Ital Chir (1990) 0.75
[Bilateral pleuro-pulmonary perforative syndrome in a patient with apparently idiopathic pulmonary fibrosis]. Arch Monaldi (1972) 0.75
[Urinary albumin excretion and coronary artery disease]. G Ital Nefrol (2006) 0.75
[Extracorporeal perfusion through the extra-situ isolated liver in the treatment of severe hepatic insufficiency]. Minerva Chir (1978) 0.75
Plurifocal breast cancer and double lymphatic spread. G Chir (2008) 0.75
[Thyroid microcarcinoma: our experience]. G Chir (2006) 0.75
[Warthin's tumor. Description of 2 cases]. Ann Ital Chir (1997) 0.75
[Thyroid nodular pathology in old age]. Minerva Chir (1986) 0.75
[Carotid glomus tumours. Personal experience in the surgical treatment of chemodectoma]. Minerva Endocrinol (2001) 0.75